/PRNewswire/ Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease and improve patients lives,.
A surgical team at the Department of Vascular Surgery at Sultan Qaboos Hospital in Salalah has managed to save the life of a sixty-year-old patient hailing from Yemen.
Data from the PROMISE II study detail the effects of transcatheter arterialization procedures with the LimFlow System for reducing the rate of amputation in people with chronic limb-threatening ischemia.